TOCILIZUMAB IS CLINICALLY EFFECTIVE AND SAFE FOR HUMAN T-LYMPHOTROPIC VIRUS TYPE 1 POSITIVE PATIENTS WITH RHEUMATOID ARTHRITIS WHO ARE NOT RESPONSIVE TO ANTI-TNF TREATMENT

被引：0
|
作者：
Umekita, K. [1 ]
Hidaka, T. [2 ]
Miyauchi, S. [1 ]
Kubo, K. [1 ]
Hashiba, Y. [1 ]
Okayama, A. [1 ]
机构：
[1] Univ Miyazaki, Fac Med, Div Pheumatol Infect Dis & Lab Med, Miyazaki, Japan
[2] Zenjinkai Shimin No Mod Hosp, Inst Rheumatol, Miyazaki, Japan
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2015年 / 74卷
关键词：
D O I：
10.1136/annrheumdis-2015-eular.1629
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
AB0124
引用
收藏
页码：932 / 932
页数：1
相关论文
共 50 条
  • [1] Human T-Lymphotropic Virus Type 1 Biomarkers in Patients with Rheumatoid Arthritis.
    Okayama, Akihiko
    Iwanaga, Masako
    Sagara, Yasuko
    Hidaka, Toshihiko
    Umekita, Kunihiko
    Nakano, Kazumi
    Watanabe, Toshiki
    Yamano, Yoshihisa
    Horai, Yoshiro
    Nakamura, Hideki
    Kawakami, Atsushi
    [J]. ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S944 - S944
  • [2] Efficacy and Safety of Tocilizumab Treatment for Anti-human T Lymphotropic Virus Type I Antibody-positive Rheumatoid Arthritis
    Endo, Yushiro
    Umekita, Kunihiko
    Nakamura, Hideki
    Fukui, Shoichi
    Suzuki, Takahisa
    Miyamoto, Junya
    Shimizu, Toshimasa
    Koga, Tomohiro
    Kawashiri, Shin-ya
    Iwamoto, Naoki
    Ichinose, Kunihiro
    Tamai, Mami
    Origuchi, Tomoki
    Okada, Akitomo
    Fujikawa, Keita
    Mizokami, Akinari
    Matsuoka, Naoki
    Aramaki, Toshiyuki
    Ueki, Yukitaka
    Eguchi, Katsumi
    Kariya, Yumi
    Hashiba, Yayoi
    Hidaka, Toshihiko
    Okayama, Akihiko
    Kawakami, Atsushi
    [J]. ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [3] TREATMENT WITH ANTI-TUMOR NECROSIS FACTOR (TNF) BIOLOGICS TO HUMAN T-LYMPHOTROPIC VIRUS TYPE 1 (HTLV-1) POSITIVE PATIENTS WITH RHEUMATOID ARTHRITIS (RA) : A CASE-CONTROL STUDY
    Miyauchi, S.
    Umekita, K.
    Hidaka, T.
    Hashiba, Y.
    Kawaguchi, T.
    Matsuda, M.
    Kubo, K.
    Ueno, S.
    Kusumoto, N.
    Takajo, I.
    Kai, Y.
    Nagatomo, Y.
    Okayama, A.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 437 - 438
  • [4] Human T-Lymphotropic Virus Type 1 Infection in a Patient with Arthritis in Mozambique: Molecular Characterization of Human T-Lymphotropic Virus Type 1 Isolate
    Caterino-de-Araujo, Adele
    Magri, Mariana Cavalheiro
    Silva Costa, Emanuela Avelar
    Rafael Manuel, Rolanda Carmen
    [J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 2011, 27 (12) : 1255 - 1257
  • [5] TREATMENT WITH TOCILIZUMAB IMPROVED RHEUMATOID ARTHRITIS PATIENTS CLINICALLY AND STRUCTURALLY REGARDLESS OF THE PRIOR USE OF ANTI-TNF BIOLOGICS IN DAILY CLINICAL PRACTICE
    Izumi, K.
    Kaneko, Y.
    Yasuoka, H.
    Seta, N.
    Kameda, H.
    Kuwana, M.
    Takeuchi, T.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 884 - 885
  • [6] Molecular targeting for treatment of human T-lymphotropic virus type 1 infection
    Soltani, Arash
    Hashemy, Seyed Isaac
    Avval, Farnaz Zahedi
    Soleimani, Anvar
    Rafatpanah, Houshang
    Rezaee, Seyed Abdorahim
    Griffith, Renate
    Mashkani, Baratali
    [J]. BIOMEDICINE & PHARMACOTHERAPY, 2019, 109 : 770 - 778
  • [7] Treatment With Anti-Tumor Necrosis Factor Biologic Agents in Human T Lymphotropic Virus Type I-Positive Patients With Rheumatoid Arthritis
    Umekita, Kunihiko
    Hidaka, Toshihiko
    Miyauchi, Shunichi
    Ueno, Shiro
    Kubo, Kazuyoshi
    Takajo, Ichiro
    Hashiba, Yayoi
    Kai, Yasufumi
    Nagatomo, Yasuhiro
    Okayama, Akihiko
    [J]. ARTHRITIS CARE & RESEARCH, 2014, 66 (05) : 788 - 792
  • [8] Use of anti-tumor necrosis factor biologics in the treatment of rheumatoid arthritis does not change human T-lymphotropic virus type 1 markers: a case series
    Umekita, Kunihiko
    Umeki, Kazumi
    Miyauchi, Shunichi
    Ueno, Shiro
    Kubo, Kazuyoshi
    Kusumoto, Norio
    Takajo, Ichiro
    Nagatomo, Yasuhiro
    Okayama, Akihiko
    [J]. MODERN RHEUMATOLOGY, 2015, 25 (05) : 794 - 797
  • [9] IL-6 May Have an Important Role in the Resistance to Anti-TNF Therapies of Human T-Lymphotropic Virus Type 1 (HTLV-1) Positive Rheumatoid Arthritis (RA) Patients; HTLV-1 Infected Cells Activate the Inflammatory Responses of RA Synovial Fibroblasts
    Umekita, Kunihiko
    Miyauchi, Shunichi
    Kubo, Kazuyoshi
    Umeki, Kazumi
    Nomura, Hajime
    Komura, Mao
    Iwao, Koushou
    Takajo, Ichiro
    Nagatomo, Yasuhiro
    Hidaka, Toshihiko
    Okayama, Akihiko
    [J]. ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [10] TREATMENT OF RHEUMATOID ARTHRITIS WITH ADALIMUMAB IS EFFECTIVE FOR PATIENTS WITH AND WITHOUT HISTORY OF OTHER ANTI-TNF THERAPIES
    Burmester, Gerd R.
    Kary, Sonja
    Unnebrink, Kristina
    Guerette, Benoit
    Oezer, Uemit
    Kupper, Hartmut
    [J]. RHEUMATOLOGY, 2010, 49 : I99 - I100
12345